Actavis’ generic breast cancer drug, Epirubicin Hydrochloride Injection, has been approved for sale in the US by the Food & Drug Administration (FDA). Epirubicin Hydrochloride
Category: Health & Pharmaceuticals
News and PR releases on Health and Pharmaceuticals
Actavis and Medis represented at CPhI
Actavis Group employees from diverse departments from all over the world will be present at this year’s annual CPhI conference, held in Frankfurt, Germany, 30
LipoSan Ultra® provides weight loss the natural way
Those interested in weight loss and weight management have found a new ally that helps them maintain their ideal weight. LipoSan Ultra® is a revolutionary
Hygiene nomination – Teknomek Industries Ltd
For 21 years, Teknomek has developed a solid reputation manufacturing and supplying high quality hygienic stainless steel equipment and furniture to the food production sector.
Almost half of Brits confused over risk of skin cancer
New research commissioned by Tesco suggests that as many as one in five (23%) Brits are not even aware of what UVA and UVB rays
Specialists in the manufacture and supply of stainless steel furniture and equipment – including bespoke fabrications
Teknomek’s knowledge of manufacturing stainless steel products spans over 20 years and with the help of state of the art sheet metal manufacturing equipment and
Gael Ltd looks at the proposed changes to EU GMP Annex 11
As the NHS celebrates its 60th birthday, healthcare organisations need to keep abreast of changing statutory health and safety compliance requirements both in the NHS
New website launched that provides guidance and solutions for heart health vitality.
Heart Health Resources will guide you through the many different factors that affect the health and vitality of your heart and body. James McCreary, the
Actavis gets approval for generic Wellbutrin in the United States
Generic drugs company Actavis has received approval from the FDA to market Bupropion Hydrochloride extended-release tablets (XL) 300mg in the US. Actavis, a leading generic
Britons are being more adventurous in choosing holiday destinations as they search for the sun
Amid the doom and gloom of a poor summer and talk of the credit crunch, increasing numbers of Britons are choosing to spend their hard earned cash on holidays in less than traditional locations. Sales of holidays in luxury destinations, such as the Caribbean, are on the up in 2008, says www.holidays-direct.co.uk.
Actavis announces senior appointments
Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international